Physiologic evaluation of the patient with lung cancer being considered for resectional surgery - ACCP evidenced-based clinical practice guidelines (2nd edition)

被引:334
作者
Colice, Gene L.
Shafazand, Shirin
Griffin, John P.
Keenan, Robert
Bolliger, Chris T.
机构
[1] Washington Hosp Ctr, Pulm Crit Care & Resp Serv, Div Pulm & Crit Care Med, Washington, DC 20010 USA
[2] George Washington Univ, Sch Med, Washington, DC USA
[3] Univ Miami, Div Pulm & Crit Care Med, Miller Sch Med, Miami, FL 33152 USA
[4] Univ Tennessee, Ctr Hlth Sci, Dept Med & Prevent Med, Div Pulm & Crit Care Med, Memphis, TN 38163 USA
[5] Allegheny Gen Hosp, Div Thorac Surg, Pittsburgh, PA 15212 USA
[6] Univ Stellenbosch, Cape Town, South Africa
[7] Tygerberg Acad Hosp, Resp Res Unit, Cape Town, South Africa
关键词
cardiopulmonary exercise testing; diffusing capacity of the lung for carbon monoxide; lung cancer; lung resection surgery; predicted postoperative lung function; preoperative assessment; spirometry;
D O I
10.1378/chest.07-1359
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: This section of the guidelines is intended to provide an evidence-based approach to the preoperative physiologic assessment of a patient being considered for surgical resection of lung cancer. Methods: Current guidelines and medical literature applicable to this issue were identified by computerized search and evaluated using standardized methods. Recommendations were framed using the approach described by the Health and Science Policy Committee. Results: The preoperative physiologic assessment should begin with a cardiovascular evaluation and spirometry to measure the FEV1. If diffuse parenchymal lung disease is evident on radiographic studies or if there is dyspnea on exertion that is clinically out of proportion to the FEV1 the diffusing capacity of the lung for carbon monoxide (DLCO) should also be measured. In patients with either an FEV1 or DLCO < SO% predicted, the likely postoperative pulmonary reserve should be estimated by either the perfusion scan method for pneumonectomy or the anatomic method, based on counting the number of segments to be removed, for lobectomy. An estimated postoperative FEV1 or DLCO < 40% predicted indicates an increased risk for perioperative complications, including death, from a standard lung cancer resection (lobectomy or greater removal of lung tissue). Cardiopulmonary exercise testing (CPET) to measure maximal oxygen consumption (Vo(2)max) should be performed to further define the perioperative risk of surgery; a Vo(2)max of < 15 ml/kg/min indicates an increased risk of perioperative complications. Alternative types of exercise testing, such as stair climbing, the shuttle walk, and the 6-min walk, should be considered if CPET is not available. Although often not performed in a standardized manner, patients who cannot climb one flight of stairs are expected to have a Vo(2)max of < 10 mL/kg/min. Data on the shuttle walk and 6-min walk are limited, but patients who cannot complete 25 shuttles on two occasions will likely have a VO(2)max of < 10 mL/kg/min. Desaturation during an exercise test has not clearly been associated with an increased risk for perioperative complications. Lung volume reduction surgery (LVRS) improves survival in selected patients with severe emphysema. Accumulating experience suggests that patients with extremely poor lung function who are deemed inoperable by conventional criteria might tolerate combined LVRS and curative-intent resection of lung cancer with an acceptable mortality rate and good postoperative outcomes. Combining LVRS and lung cancer resection should be considered in patients with a cancer in an area of upper lobe emphysema, an FEV1 of > 20% predicted, and a DLCO of > 20% predicted. Conclusions: A careful preoperative physiologic assessment will be useful to identify those patients who are at increased risk with standard lung cancer resection and to enable an informed decision by the patient about the appropriate therapeutic approach to treating their lung cancer. This preoperative risk assessment must be placed in the context that surgery for early-stage lung cancer is the most effective currently available treatment for this disease.
引用
收藏
页码:161S / 177S
页数:17
相关论文
共 142 条
[1]  
ALI MK, 1980, CHEST, V77, P337, DOI 10.1378/chest.77.3.337
[2]  
ALI MK, 1983, J THORAC CARDIOV SUR, V86, P1
[3]  
Allen G M, 1997, AORN J, V66, P808, DOI 10.1016/S0001-2092(06)62662-8
[4]  
*AM COLL RAD EXP P, 2000, NONSM CELL LUNG CANC
[5]  
[Anonymous], MAN PAT LUNG CANC
[6]  
[Anonymous], ONC PAT MAN GUID VER
[7]   Influence of delays on survival in the surgical treatment of bronchogenic carcinoma [J].
Aragoneses, FG ;
Moreno, N ;
Leon, P ;
Fontan, EG ;
Folque, E .
LUNG CANCER, 2002, 36 (01) :59-63
[8]   The influence of hospital volume on survival after resection for lung cancer [J].
Bach, PB ;
Cramer, LD ;
Schrag, D ;
Downey, RJ ;
Gelfand, SE ;
Begg, CB .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :181-188
[9]   Smoking and timing of cessation - Impact on pulmonary complications after thoracotomy [J].
Barrera, R ;
Shi, WJ ;
Amar, D ;
Thaler, HT ;
Gabovich, N ;
Bains, MS ;
White, DA .
CHEST, 2005, 127 (06) :1977-1983
[10]   Lung cancer resection - The prediction of postsurgical outcomes should include long-term functional [J].
Beccaria, M ;
Corsico, A ;
Fulgoni, P ;
Zoia, MC ;
Casali, L ;
Orlandoni, G ;
Cerveri, I .
CHEST, 2001, 120 (01) :37-42